The Government of India, through the National Pharmaceutical Pricing Authority (NPPA), has capped the trade margin at 30% on 137 anti-cancer medicines. The aim is to make cancer treatment more affordable for patients.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
GENX Division offers a comprehensive range of pharmaceutical solutions that focus on improving patient care across key healthcare divisions. It focuses on allergy care, infectious diseases, digestive health, cardiovascular wellness, skin care, smoking cessation, and nutritional supplementation. GENX prioritises reliable treatment options supported by scientific expertise and high-quality standards. The division's commitment to excellence continues to help improve healthcare access and quality of life.
View by-
